How Apple Watch ECG Changed the FDA Approval Process

In this episode, Lucas and Luna explore how the Apple Watch's FDA-cleared ECG feature fundamentally altered the regulatory pathway for consumer health wearables. They trace the 2018 landmark decision that allowed a mass-market device to claim medical-grade heart rhythm monitoring, and examine the ripple effects on startups like AliveCor and Fitbit. The conversation dives into the practical trade-offs: sensitivity vs. specificity, the burden of false positives, and what the data from over 100 million wearables actually tells cardiologists. Lucas brings the numbers from Apple's own atrial fibrillation study published in the New England Journal of Medicine, while Luna challenges whether FDA clearance is meaningful without peer-reviewed accuracy benchmarks. They also touch on the current regulatory bottleneck at the FDA's Digital Health Center of Excellence, and whether the agency has the bandwidth to vet 200+ new device applications per year. A must-listen for anyone tracking the collision between consumer electronics and regulated medicine. #AppleWatchECG #FDA #WearableHealth #AtrialFibrillation #AliveCor #Fitbit #DigitalHealth #Regulatory #Cardiology #HealthTech #ClinicalValidation #SensitivityVsSpecificity #ConsumerWearables #NEJM #HealthData #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo